Carcinoembryonic antigen (CEA) and cancer antigen 15–3 (CA15–3) are commonly used biomarkers for BC detection, which are usually elevated in advanced stages and have low sensitivity and specificity in the diagnosis of early-stage BC [9,10]. The gene discussed is CEACAM5; the disease is breast cancer.